ALICIA CICCONE: "Drop Seizure Frequency in Lennox-Gastaut Decreased With Cannabidiol", NEUROLOGY ADVISOR, 26 April 2017 (2017-04-26), pages 1 - 3, XP055544182, Retrieved from the Internet <URL:https://www.neurologyadvisor.com/aan-2017-coverage/aan-2017-cannabidiol-reduces-drop-seizures-in-lennox-gastaut-syndrome/article/652931/> [retrieved on 20190117] (B1)

DEVINSKY ORRIN ET AL: "Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial", LANCET NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, vol. 15, no. 3, 24 December 2015 (2015-12-24), pages 270 - 278, XP029415431, ISSN: 1474-4422, DOI: 10.1016/S1474-4422(15)00379-8 (B1)

GB-A- 2 531 282 (B1)

WIRRELL E ET AL: "Cannabidiol (CBD) significantly reduces drop and total seizure frequency in lennox gastaut syndrome (LGS): Results of a dose ranging, multicenter, randomized, double blind, placebo controlled trial (GWPCARE3)", 1 October 2017 (2017-10-01), XP002788724, Retrieved from the Internet <URL:http://ir.gwpharm.com/static-files/d489e19a-7769-4dcb-97fc-60ed923b0a2d> (B1)

OSTENDORF ADAM ET AL: "Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions", NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol. Volume 13, 1 April 2017 (2017-04-01), pages 1131 - 1140, XP055939166, Retrieved from the Internet <URL:https://www.dovepress.com/getfile.php?fileID=36134> [retrieved on 20220706], DOI: 10.2147/NDT.S115996 (B1)

US-A1- 2017 224 634 (B1)

O DEVINSKY ET AL: "Efficacy and safety of Epidiolex (cannabidiol) in children and young adults with treatment-resistant epilepsy: Initial data from expanded access program", 1 January 2015 (2015-01-01), XP055553292, Retrieved from the Internet <URL:https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/2414222> [retrieved on 20190207] (B1)